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TaiwanA B S T R A C TObjectives: To investigate the monthly number of prescribed med-
ication (NPM) patterns among different elderly populations and the
factors associated with monthly NPM changes. Methods: This
retrospective cohort study was conducted using the databases
obtained from National Health Insurance Research Databases and
a 2000-bed academic medical center in Taiwan (i.e., single-center
cohort). We compared the monthly NPMs, demographic character-
istics, disease states, and health care contacts among the National
Health Insurance elderly cohorts in 2006 and 2007, and for those
elderly in the national and single-center cohorts who had out-
patient visits from November to October in 2006 to 2007 and 2007 to
2008, respectively. Generalized estimating equation analyses of
repeated measures were performed for monthly NPMs. Results:
The average monthly NPMs among the National Health Insurance
elderly cohort was 2.33 in 2006 and 4.39 in 2007, respectively. After
controlling for other factors, the increment in the proportion ofee front matter Copyright & 2015, International S
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sueh-Shih Road, Taichung, Taiwan 40402, China.monthly NPMs among the older elderly patients, in certain months
and for those patients with hypertension and dyslipidemia, was
statistically signiﬁcant among the single-center cohort but was not
observed in the national elderly cohort. The proportional changes
decreased signiﬁcantly among patients who made visits to emer-
gency rooms and who were hospitalized during a 1-year period.
Conclusions: There was an incremental trend of monthly NPMs
among the national cohort from 2006 to 2007. Although acute
exacerbations and hospitalization might be the protecting factors
of increasing monthly NPMs, more attention should be paid toward
high-utilization patients with speciﬁc diseases during certain
months for different elderly cohorts.
Keywords: elderly, monthly, number of prescribed medications.
Copyright & 2015, International Society for Pharmacoeconomics and
Outcomes Research (ISPOR). Published by Elsevier Inc.Introduction
Managing medication for frail elderly patients is a huge challenge
because they are very likely to be given medications inappropri-
ately, including encountering the problem of polypharmacy [1,2].
Although polypharmacy is a common problem among the elderly
who have more chronic diseases and more contacts with differ-
ent prescribers [3–6], it is unclear whether the polypharmacy
occurred on individual elderly per se over times.
The World Health Organization/International Network of
Rational Use of Drugs (WHO/INRUD) recommends using the
“average number of medicines prescribed per patient encounter”
as “prescribing indicators” to evaluate problems of medication use
for antibiotics [7]. Schneeweiss et al. [8] recommend using thenumber of distinct medications received on an individual patient
within 1 year to explore the extent of medication use patterns and
the impact on future physician ofﬁce visits, medical expenditure,
and patients’ mortality. Although older patients with chronic
conditions are very likely to be added on or withdrawn from any
speciﬁc drug and/or drug classes across times [9], it is expected
that the NPMs received by the individual elderly might be changed
dynamically or remain the same whenever the condition is stable.
To help health care policy decision makers in formulating
appropriate strategies to mitigate problems with a system that
involves elderly patients using various prescribers and visiting
multiple hospital settings, the objectives of this study were to
compare the monthly number of prescribed medication (NPM)
patterns received from outpatient visits among the differentociety for Pharmacoeconomics and Outcomes Research (ISPOR).
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Table 1 – Effect of change in NPMs by proposed factors.
Parameter National elderly cohort Single-center elderly cohort
Est. SE 95% CI Z Pr 4 |Z| Est. SE 95% CI Z Pr 4 |Z|
Intercept 1.4661 0.0097 1.447 1.4852 150.5 o0.0001 1.055 0.0193 1.0171 1.0929 54.54 o0.0001
Demographic characteristic
Sex: female 0.0268 0.0042 0.0186 0.035 6.43 o0.0001 0.0102 0.0093 0.008 0.0284 1.1 0.2726
Age 70–74 y 0.0121 0.0056 0.0012 0.0231 2.17 0.0303 0.0459 0.0129 0.0206 0.0712 3.56 0.0004
Age 75–79 y 0.0054 0.0062 0.0067 0.0174 0.87 0.3832 0.0794 0.0132 0.0535 0.1053 6 o0.0001
Age 80–85 y 0.005 0.0064 0.0076 0.0175 0.77 0.4384 0.0694 0.0153 0.0395 0.0993 4.55 o0.0001
Age Z85 y 0.0067 0.0076 0.0215 0.0081 0.89 0.3740 0.0740 0.0185 0.0377 0.1103 3.99 o0.0001
Disease status
No. of ICD 4 6 0.1143 0.0091 0.1322 0.0963 12.50 o0.0001 0.2125 0.0093 0.1942 0.2308 22.75 o0.0001
With DM 0.1642 0.005 0.1544 0.1741 32.64 o0.0001 0.1893 0.0101 0.1694 0.2092 18.65 o0.0001
With HTN 0.0028 0.0046 0.0062 0.0119 0.62 0.5371 0.1612 0.01 0.1416 0.1808 16.08 o0.0001
With LIP 0.0055 0.0052 0.0046 0.0157 1.07 0.2825 0.0716 0.0106 0.0509 0.0924 6.76 o0.0001
With CVD 0.1155 0.0066 0.1026 0.1285 17.52 o0.0001 0.1547 0.0109 0.1333 0.1761 14.17 o0.0001
With IHD 0.0495 0.0049 0.0399 0.0592 10.02 o0.0001 0.2272 0.0106 0.2064 0.248 21.42 o0.0001
With HEPA 0.0142 0.0081 0.0301 0.0018 1.74 0.0818 0.0041 0.0185 0.0323 0.0404 0.22 0.8268
With CKD 0.5552 0.0225 0.511 0.5993 24.62 o0.0001 0.285 0.017 0.2517 0.3182 16.79 o0.0001
With LUNG 0.0632 0.0049 0.0536 0.0728 12.89 o0.0001 0.2205 0.0128 0.1954 0.2456 17.22 o0.0001
With CANCER 0.0405 0.0085 0.0238 0.0572 4.74 o0.0001 0.0447 0.0167 0.012 0.0773 2.68 0.0074
Health care contact
No. of OPD visits 4 8 0.1416 0.0090 0.1239 0.1592 15.73 o0.0001 1.0579 0.0164 1.0257 1.0901 64.37 o0.0001
Ever admit ER 0.0803 0.0059 0.0919 0.0687 13.6 o0.0001 0.0339 0.0139 0.0612 0.0066 2.43 0.015
Ever hospitalization 0.0295 0.0055 0.0403 0.0186 5.33 o0.0001 0.0741 0.0131 0.0998 0.0485 5.66 o0.0001
Month (2006–2007 for national elderly cohort and 2007–2008 for MC elderly cohort)
November 0.6621 0.004 0.6699 0.6542 165.17 o0.0001 0.146 0.0067 0.1328 0.1591 21.77 o0.0001
December 0.648 0.0041 0.6561 0.6399 156.73 o0.0001 0.1312 0.0065 0.1184 0.144 20.08 o0.0001
January 0.0121 0.004 0.0042 0.02 3 0.0027 0.1435 0.0063 0.1312 0.1558 22.92 o0.0001
February 0.004 0.0039 0.0037 0.0117 1.01 0.3137 0.0422 0.0064 0.0296 0.0548 6.56 o0.0001
March 0.0119 0.004 0.0041 0.0198 2.97 0.003 0.0914 0.006 0.0796 0.1031 15.23 o0.0001
April 0.0008 0.0039 0.0085 0.0069 0.2 0.8414 0.0745 0.0057 0.0634 0.0856 13.16 o0.0001
May 0.0069 0.0039 0.0145 0.0006 1.79 0.0731 0.0493 0.0054 0.0388 0.0598 9.2 o0.0001
June 0.009 0.0039 0.0167 0.0012 2.28 0.0229 0.0343 0.0052 0.024 0.0445 6.54 o0.0001
July 0.0078 0.0038 0.0154 0.0003 2.04 0.0411 0.0282 0.0048 0.0188 0.0377 5.86 o0.0001
September 0.0039 0.0038 0.0035 0.0113 1.04 0.3 0.0033 0.0049 0.0129 0.0063 0.68 0.4985
October 0.1042 0.0041 0.1122 0.0962 25.44 o0.0001 0.0305 0.0053 0.0201 0.0409 5.75 o0.0001
Note. The reference month is August. Reference subjects: those who had no DM, no HTN, no LIP, no CVD, no IHD, no HEPA, no CKD, no OPD, with no hospitalization experience, with no ER
experience, were men, aged 65–70 y.
CANCER, top 10 cancers; CI, conﬁdence interval; CKD, chronic kidney disease; CVD, cerebrovascular disease; DM, diabetes mellitus; ER, emergency room; Est., estimation; HEPA, chronic hepatitis;
HTN, hypertension; ICD, International Classiﬁcation of Diseases; IHD, ischemia heart disease; LIP, hyperlipidemia; LUNG, respiratory diseases; MC, Medical Center; NPM, number of prescribed
medications; OPD, outpatient department; SE standard error.
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with their changes in NPMs.Methods
Study Design
The retrospective cohort study was conducted using different
data resources for different time periods.
Data Sources
First, we used the sampling claim data of 1 million beneﬁciaries
from the Longitudinal Health Insurance Database 2005
(LHID2005), which was randomly sampled from the 2005 beneﬁ-
ciary registry of the National Health Insurance Research Data-
bases (i.e., represents approximately 25.68 million individuals).
We retrieved and evaluated the information of patients’ demo-
graphic characteristics, disease states, and health care contacts.
Second, we retrieved and assessed the corresponding relevant
data from the in-house medical record database of a 2000-bed
academic medical center, China Medical University Hospital
(CMUH), in Taiwan.
Study Subjects and Timelines
First, we focused on those National Health Insurance (NHI) bene-
ﬁciaries who were aged 65 years or older before January 2006 and
January 2007 and identiﬁed them as “2006 NHI sampling elderly
beneﬁciaries” and “2007 NHI sampling elderly beneﬁciaries,”
respectively. The subgroup of 2007 NHI sampling elderly beneﬁ-
ciaries who had outpatient visits at any medical center in Taiwan
in 2007 was extracted and deﬁned as the “NHI MC elderly cohort.”
Those NHI sampling elderly beneﬁciaries who had outpatient visits
between November 1, 2006, and October 31, 2007, were named the
“national elderly cohort” and were further evaluated to explore the
factors associated with the change in NPMs received from different
settings or prescribed by different physicians. There is no direct
method to identify where the elderly cohort had outpatient visits
at speciﬁc hospital settings using the LHID2005 because the
corresponding information was encrypted. Therefore, we used
the elderly patient sample selected from CMUH’s medical records
to describe the elderly NHI beneﬁciaries who had outpatient visit(s)
at a “speciﬁc” academic medical center in Taiwan (named as the
“single-center elderly cohort”) in the subsequent year of the same
period (i.e., November 1, 2007, and October 31, 2008) and compared
their factors associated with the change in NPMs in the CMUH with
those of the “national elderly cohort.”
Focuses of Assessment
Under NHI implementation in Taiwan, the covered distinct items of
medication could be prescribed by one or more physicians for
individual patients because NHI beneﬁciaries could visit different
hospitals and/or different physician specialists with very few
restrictions. Therefore, we deﬁned the NPM as the number of
distinct Western medications prescribed by various physicians
from various outpatient visits among the cohorts of patients within
1 month, similar to the deﬁnition in Schneeweiss et al’s study [8],
instead of using the deﬁnition, “per patient encounter,” recom-
mended by the WHO/INRUD [7]. The medications of interest
included medicines used for acute or chronic diseases, and/or
continuously reﬁlled prescriptions, but excluded NHI-covered tradi-
tional Chinese medicines. Outpatient visits included both primary
clinics in the communities and physician clinics in the outpatient
departments (OPDs) in any contracted medical institute for the NHI
sampling beneﬁciaries and the national cohort. Although WHO/INRUD drug use indicators accounted for the components of
patient care, facility, and complementary drug use [7], we were
interested in knowing whether the patients’ demographic informa-
tion, disease state, health care contacts, and prescription months,
as in Chang et al’s study [10], were associated with proportional
changes in the NPMs. The common diseases of diabetes mellitus,
hyperlipidemia, hypertension (HTN), cerebrovascular diseases,
ischemic heart diseases, chronic hepatitis, chronic kidney disease,
respiratory diseases, top 10 cancers, and patients’ health care
utilization recorded in the corresponding databases within the
observation periods were of interest for further evaluation.
Statistical Analysis
Monthly NPMs of 2007 NHI MC elderly cohort were compared with
those obtained from the data of 2006 and 2007 NHI sampling elderly
beneﬁciaries. We performed the analyses using generalized esti-
mating equations of repeated measures for monthly NPMs to
examine the factors potentially associated with the national and
single-center elderly cohorts. The reference month was August. The
reference subjects for these two cohorts were elderly men aged 65
to 70 years old who did not have diagnoses of diabetes mellitus,
HTN, hyperlipidemia, cerebrovascular diseases, ischemic heart
diseases, chronic hepatitis, chronic kidney disease, respiratory
diseases, or top 10 cancers. In addition, these subjects should have
no OPD visits, no hospitalization record, and no emergency room
visits during the observation period, based on the LHID2005 and
CMUH databases.
Ethics Statement
The analyses of the LHID2005 were exempt from the Institutional
Review Board approval because the National Health Insurance
Research Databases contain de-identiﬁed person and de-
identiﬁed institution information, which was publicly available
through a regulated application process. The use of CMUH data-
bases was approved by the Research Ethic Committee in the
China Medical University and the CMUH (institutional review
board approved nos. DMR99-IRB-116 and DMR99-IRB-116-1).Results
Comparisons of 2006, 2007 NHI Elderly Beneﬁciaries and NHI
MC Elderly Cohort
There were 91,869 elderly patients in 2006 and 94,554 in 2007
among the 1 million randomized samples of NHI beneﬁciaries.
The demographic characteristics, disease states, and health
utilization within the 1-year observation period among the
sampling elderly beneﬁciaries in 2006 and 2007 were similar.
The patterns of monthly NPMs across months among the two
cohorts of NHI sampling elderly beneﬁciaries were also similar
but decreased in October. The average monthly NPMs in 2007 was
approximately two items more than that in 2006 (4.39 vs. 2.33)
(Fig. 1). There was approximately one more average NPM among
the 2007 NHI MC cohort across months (mean NPM ¼ 5.19  3.35)
than that of all 2007 NHI sampling elderly beneﬁciaries.
Contributing Factors Associated with the Average NPMs
The average NPMs in 1 month among the single-center elderly
cohort was approximately one and a half more medications than
that among the national elderly cohort (5.61 vs. 4.06). After adjust-
ing for the other factors, the proportional change in the NPMs (i.e.,
Z) in some months was signiﬁcantly reduced or increased in either
cohort (Table 1). In particular, the proportional change in the
monthly NPMs in October among the national elderly cohort was
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Fig. 1 – Number of prescribed medication trends among NHI elderly beneﬁciaries in 2006 and 2007 and elderly made visits toward
medical centers in 2007 (NHI MC elderly cohort). APR, April; AUG, August; DEC, December; FEB, February; JAN, January; JUL, July;
JUN, June; MAR, March; MC, medical center; NHI, National Health Insurance; NOV, November; OCT, October; SEP, September.
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decrease of around seven distinct items of medication during 31
days in October, compared to that in August) but was 5.75% more
among the single-center elderly cohort in 2008 (i.e., increase of
more than one distinct item of medication during 31 days in
October, compared to that in August). The average NPMs among
the single-center elderly cohort was relatively less in February than
in prior and later months. The proportional change in the monthly
NPMs increased signiﬁcantly among those who were diagnosed
with HTN and hyperlipidemia in the single-center elderly cohort
but was not observed in the national elderly cohort.
In both cohorts, the proportional change in the monthly NPMs
was increased signiﬁcantly and clinically among those who were
diagnosed with certain diseases (e.g., diabetes mellitus, cerebrovas-
cular diseases, and chronic kidney disease), among those patients
aged from 70 to 74 years, and among those with more than eight
OPD visits within 1 year, and was reduced among patients who
made visits to emergency rooms and had hospitalizations during
the observation period, as compared with the reference patients.Discussion
To our knowledge, this is the ﬁrst study to report the monthly
NPM patterns among the different elderly populations. We found
that the average NPMs across months was approximately two
more items among NHI elderly beneﬁciaries in 2007 than in 2006
in Taiwan. After controlling for other factors, we found that the
increment in the proportion of monthly NPMs among the older
patients, in certain months and for those patients with HTN and
dyslipidemia, was statistically signiﬁcant among the single-
center elderly cohort. This phenomenon, however, was not
observed in the national elderly cohort.
We found that the average monthly NPMs of our 2006 national
elderly cohort (i.e., 2.33) in this study was not overly different from
that of the 2007 Sudan general population [11]. Our average
monthly NPMs, however, was less than that in the study focusing
on elderly patients from 1994 to 1997 in The Netherlands (i.e., 2.6–
3.6) [6]. Although the demographic characteristics, disease states,
and health care utilization were almost the same in magnitude for
2-year NHI sampling elderly cohorts, there is no clear answer why
we observed approximately two more items in 2007 than in 2006.
We presumed that it is very likely that the Bureau of NationalHealth Insurance adjustments in reimbursement rates for the
covered medications might be one of the rationales [12]. Although
Lee et al.’s [13] study revealed the positive impact of cost-
containment strategies on covered medications in Taiwan, Chen
et al.’s [12] study inferred a negative impact of price adjustment
actions. In fact, there were two adjustment actions ofﬁcially
launched on November 1, 2006, and September 1, 2007. Only a
short-term reduction in NPM patterns in October among NHI
elderly beneﬁciaries in both years, however, was observed. Regard-
less, it is necessary to have comprehensive and continuous
assessments of medication use across months after the imple-
mentation of pharmaceutical policy in the future.
Patient satisfaction and outcomes of care were discovered to
be signiﬁcantly related to hospital location, size, case complexity,
availability of services, clinical capabilities, and process of care
[14,15]. Therefore, we found that multiple contacts for outpatient
services across settings and/or across physician specialists in
both cohorts was one of the factors that was statistically
associated with incremental NPMs, which corresponded to the
ﬁndings in the other polypharmacy study [16].
The deﬁned monthly NPMs could be an appropriate indicator
for assessing quality of care, but only if the comparisons were
made on the basis of various patient characteristics, time, spe-
cialty, and levels of hospitals. In our study, we found that older
elderly patients in speciﬁc months (i.e., February, April, and May)
and patients with HTN and dyslipidemia were statistically asso-
ciated with incremental proportions of monthly NPMs in the
single-center elderly cohort but not in the national elderly cohort.
The protective effects on incremental NPMs were revealed because
of emergent hospitalization and negative effects on incremental
NPMs as a result of more OPD visits in this study. Such ﬁndings
were different from those of the study conducted by Dellasega
et al. [17] in the United States for different patient populations in
1997. We presumed that the ﬁlling or reﬁlling of medications,
especially for chronic diseases, might be discontinued during
hospitalizations or sometimes afterward in Taiwan’s health care
system as compared with that in the other country [18].
Interestingly, the incremental trends of monthly NPMs were
signiﬁcantly higher before and after the Traditional Chinese New
Year holiday (February in 2007 and 2008), after controlling for other
factors. This trend was more profound among the single-center
elderly cohort than among the national elderly cohort. This might
be due to the calendar effect of Chinese New Year [13] because
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CMUH) are usually closed for 3 to 5 days, or even longer, over
the holiday. Although the patients’ medication use behaviors were
affected by social, cultural, and political-economic factors [19], it is
necessary to take into account the patients’ personal beliefs about
medication use, preferences, and social situations when organiz-
ing a comprehensive medication reconciliation approach [20].
There were some limitations of this study. First, the deﬁnition
of monthly NPMs, in terms of included types of medications,
covered duration, and approach of item estimation, might be
different from that in the other studies [1,16] or the WHO/INRUD
prescriber indicator [7]. We adapted the same deﬁnition of the
number of distinct medications used in Schneeweiss et al.’s [8]
study, which corresponds to the actual outpatient prescription
patterns within a period of time for patients per se. Second, there is
limited information describing actual medication use patterns
using the obtained databases, although the accuracy of the
National Health Insurance Research Databases has been validated
for various other diseases [21]. Therefore, we identiﬁed the cases
and used the same deﬁnitions of variables and assumptions as the
previous study [21]. Furthermore, the in-house CMUH databases
are meant to be the same as the encrypted data submitted to the
Bureau of National Health Insurance for monthly reimbursement.
Third, it is very likely to encounter type I errors with such a large
sample size. The interpretation of monthly NPMs proportional
change (i.e., Z) for clinical signiﬁcance would be more important
than the statistical signiﬁcance (i.e., P-value) on the generalized
estimating equation analyses. Fourth, the inferential analyses
were performed for national and single-center elderly cohorts
during the same period but in different years. The characteristics
of the single-center elderly cohort, for sure, were not the same as
that of the national elderly cohort. The average and patterns of
monthly NPMs among the single-center elderly cohort could be
underestimated because their prescribed medications from other
medical institutes were not counted. The average monthly NPMs
of the CMUH, however, was almost the same in 2007 and 2008
according to internal records and it was very close to that of the
NHI MC elderly cohort in 2007. Nevertheless, the comparisons of
single-center data with national data are beneﬁcial to facilitate the
appropriate health policy decision making within one institute
and/or across different levels of health care settings from different
administrators’ perspectives.
Overall, these ﬁndings are informative to facilitate improve-
ment in the quality of medical care at the national level and in an
individual medical center for medication use management
among the elderly. Future studies that involve multiple institutes
and from different countries, however, will be needed to verify
the ﬁndings and enhance the generalizability of this study.Conclusions
After examining the NPM patterns across months for the national
and single-center elderly cohorts in Taiwan, we have observed an
incremental trend in NPMs among the national elderly popula-
tion. Although acute exacerbations and being admitted to in-
patient services might be protecting factors of increasing
monthly NPMs, more attention should be paid toward high-
utilization patients with speciﬁc diseases in certain months
either in national or in single-center cohorts.Acknowledgments
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